Related Experiment Video

Updated: May 5, 2026

Interictal High Frequency Oscillations Detected with Simultaneous Magnetoencephalography and Electroencephalography as Biomarker of Pediatric Epilepsy
10:22

Interictal High Frequency Oscillations Detected with Simultaneous Magnetoencephalography and Electroencephalography as Biomarker of Pediatric Epilepsy

Published on: December 6, 2016

22.8K

The ketogenic diet for the treatment of pediatric status epilepticus

Sunila E O'Connor1, Margie A Ream, Candy Richardson2

  • 1Department of Pediatrics, Section of Epilepsy, Lurie Children's Hospital, Chicago, Illinois.

Pediatric Neurology
|November 30, 2013
PubMed

Insights

Refractory status epilepticus in children can be effectively managed using the ketogenic diet. This dietary therapy offers a promising alternative for pediatric patients with difficult-to-treat seizures.

Area of Science:

  • Pediatric Neurology
  • Dietary Therapies
  • Epilepsy Management

Background:

  • Refractory status epilepticus (RSE) in children presents significant morbidity and mortality risks.
  • Conventional RSE treatments involve multiple anticonvulsants and potentially induced medical comas.
  • The ketogenic diet is a well-established therapy for intractable epilepsy.

Purpose of the Study:

  • To report a case series of pediatric patients with RSE.
  • To evaluate the efficacy of the ketogenic diet in managing RSE.
  • To present the ketogenic diet as a viable treatment option for RSE.

Main Methods:

  • A retrospective summary of pediatric patients diagnosed with RSE.
  • Analysis of patients treated with the ketogenic diet.
  • Case series methodology to document outcomes.

Main Results:

  • Successful management of refractory status epilepticus was achieved in all five patients utilizing the ketogenic diet.
  • The ketogenic diet demonstrated effectiveness in controlling seizures in this pediatric cohort.
  • No adverse events were reported during the dietary intervention.

Conclusions:

  • The ketogenic diet is a safe and effective treatment option for pediatric refractory status epilepticus.
  • Consideration of ketogenic diet therapy is recommended for children with RSE.
  • Further research into ketogenic diet mechanisms for RSE is warranted.
Abstract

Keywords:
epilepsyketogenic dietpediatricrefractorystatus epilepticustreatment

More Related Videos

Long-term Continuous EEG Monitoring in Small Rodent Models of Human Disease Using the Epoch Wireless Transmitter System08:43

Long-term Continuous EEG Monitoring in Small Rodent Models of Human Disease Using the Epoch Wireless Transmitter System

Published on: July 21, 2015

25.6K
Behavioral Characterization of Pentylenetetrazole-induced Seizures: Moving Beyond the Racine Scale07:35

Behavioral Characterization of Pentylenetetrazole-induced Seizures: Moving Beyond the Racine Scale

Published on: July 8, 2025

1.8K

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.8K
Diabetic Ketoacidosis ll: Pathophysiology01:22

Diabetic Ketoacidosis ll: Pathophysiology

Diabetic ketoacidosis (DKA) is a metabolic emergency characterized by hyperglycemia, ketonemia, and metabolic acidosis. It results from severe insulin deficiency and an excess of counterregulatory hormones, leading to uncontrolled lipolysis, ketogenesis, and widespread electrolyte and fluid disturbances.Pathophysiology The central event in DKA is a profound loss of insulin action. Without insulin, glucose uptake in insulin-dependent tissues is impaired, while hepatic glucose production...
41
Diabetic Ketoacidosis l: Introduction01:25

Diabetic Ketoacidosis l: Introduction

DefinitionDiabetic ketoacidosis (DKA) is an acute, life-threatening complication of diabetes mellitus, characterized by a triad of hyperglycemia (blood glucose >250 mg/dL), ketonemia or ketonuria, and metabolic acidosis (arterial pH <7.30 and serum bicarbonate <18 mEq/L). It results from insulin deficiency combined with elevated levels of counterregulatory hormones—glucagon, catecholamines, cortisol, and growth hormone—leading to increased lipolysis, hepatic...
41
Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
2.5K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
414
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
413